Literature DB >> 21489559

Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test.

Anpalakan Sathasivam1, Henrietta Kotlus Rosenberg, Sofia Shapiro, Hong Wang, Robert Rapaport.   

Abstract

OBJECTIVE: To compare the ovarian and uterine structure demonstrated sonographically with baseline and leuprolide-stimulated luteinizing hormone (LH) and estradiol values in females with suspected precocious puberty. STUDY
DESIGN: Retrospective chart review. Fifty females (age 3.1 to 9.5 years) underwent stimulation testing with leuprolide (20 μg/kg) and pelvic ultrasonography. Subjects were grouped as (1) prepubertal (baseline and stimulated LH and estradiol in prepubertal range); (2) early pubertal (baseline LH and estradiol in prepubertal range but stimulated LH or estradiol in pubertal range); and (3) pubertal (baseline and stimulated LH or estradiol in pubertal range). Sonographic data were compared with baseline and leuprolide-stimulated LH and estradiol.
RESULTS: Baseline and stimulated LH and stimulated estradiol significantly correlated with ovarian and uterine volumes. Ovarian and uterine volumes were significantly higher in females in the pubertal group than in females in the prepubertal group. No significant differences were noted in the ovarian or uterine dimensions between the prepubertal and early pubertal groups. There was significant overlap in ovarian and uterine volumes among females in all three groups.
CONCLUSION: Contrary to leuprolide stimulation, pelvic ultrasonography alone cannot distinguish between prepubertal females and those in the early stages of puberty.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489559     DOI: 10.1016/j.jpeds.2011.02.032

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Precocious puberty--perspectives on diagnosis and management.

Authors:  P S N Menon; M Vijayakumar
Journal:  Indian J Pediatr       Date:  2013-09-07       Impact factor: 1.967

2.  Homozygous SHBG Variant (rs6258) Linked to Gonadotropin-Independent Precocious Puberty in a Young Girl.

Authors:  Victoria C Andriessen; Marissa Lightbourne; Chelsi Flippo; Fabio R Faucz; Angela Delaney; Fady Hannah-Shmouni; Geoffrey L Hammond; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2021-07-19

3.  Precocious puberty: An experience from a major teaching hospital in Central Saudi Arabia.

Authors:  Huda A Osman; Nasir A M Al-Jurayyan; Amir M I Babiker; Hessah M N Al-Otaibi; Reem D H AlKhalifah; Sharifah D A Al Issa; Sarar Mohamed
Journal:  Sudan J Paediatr       Date:  2017

4.  Clinical risk score for central precocious puberty among girls with precocious pubertal development: a cross sectional study.

Authors:  Jingyu You; Xianying Cheng; Xiaojing Li; Mingqing Li; Li Yao; Feihong Luo; Ruoqian Cheng; Li Xi; Jiangfeng Ye
Journal:  BMC Endocr Disord       Date:  2021-04-20       Impact factor: 2.763

5.  The role of pelvic ultrasound for the diagnosis and management of central precocious puberty: An update.

Authors:  Valentina Talarico; Maria Benedetta Rodio; Antonio Viscomi; Eulalia Galea; Maria Concetta Galati; Giuseppe Raiola
Journal:  Acta Biomed       Date:  2021-11-04

6.  Usefulness of pelvic ultrasonography for the diagnosis of central precocious puberty in girls.

Authors:  Jung Yu; Ha Young Shin; Sun Hee Lee; You Sung Kim; Jae Hyun Kim
Journal:  Korean J Pediatr       Date:  2015-08-21

7.  Machine learning identifies girls with central precocious puberty based on multisource data.

Authors:  Liyan Pan; Guangjian Liu; Xiaojian Mao; Huiying Liang
Journal:  JAMIA Open       Date:  2020-12-05

8.  The Use of Morning Urinary Gonadotropins and Sex Hormones in the Management of Early Puberty in Chinese Girls.

Authors:  Shumin Zhan; Ke Huang; Wei Wu; Danni Zhang; Ana Liu; Robert M Dorazio; Jianrong Shi; Rahim Ullah; Li Zhang; Jinling Wang; Guanping Dong; Yan Ni; Junfen Fu
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.